Dr. Korn is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3501 N Scottsdale Rd
Ste 130
Scottsdale, AZ 85251Phone+1 480-425-5000Fax+1 480-945-6548
Education & Training
- University of Pennsylvania Health SystemFellowship, Nuclear Radiology, 1991 - 1996
- Kaiser Permanente Northern California (Santa Clara)Internship, Internal Medicine, 1990 - 1991
- Stanford University School of MedicineClass of 1990
Certifications & Licensure
- AZ State Medical License 1996 - 2025
- WA State Medical License Active through 2013
- PA State Medical License 1991 - 2002
- American Board of Nuclear Medicine Nuclear Medicine
- American Board of Radiology Diagnostic Radiology
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
- Top MD Consumers Checkbook
Clinical Trials
- F18PET/CT Versus TC-MDP Scanning to Detect Bone Mets Start of enrollment: 2009 Jan 01
- A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD. Start of enrollment: 2011 Jun 01
- Analysis of 18F-AV-1451 PET Imaging in Cognitively Healthy, MCI, and AD Subjects Start of enrollment: 2013 Dec 01
Publications & Presentations
PubMed
- 4 citationsFirst-in-Human Phase I Study of Minnelide in Patients With Advanced Gastrointestinal Cancers: Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity.Erkut Borazanci, Ashok Saluja, Jon Gockerman, Mohana Velagapudi, Ronald Korn
The Oncologist. 2024-02-02 - 231 citationsPhase Ib Study of PEGylated Recombinant Human Hyaluronidase and Gemcitabine in Patients with Advanced Pancreatic Cancer.Sunil R. Hingorani, William P. Harris, J. Thaddeus Beck, Boris A. Berdov, Stephanie Ann Wagner
Clinical Cancer Research. 2016-01-26 - 814 citationsGemcitabine Plus nab-Paclitaxel Is an Active Regimen in Patients With Advanced Pancreatic Cancer: A Phase I/II TrialDaniel D. Von Hoff, Ramesh K. Ramanathan, Mitesh J. Borad, Daniel A. Laheru, Lon Smith
Journal of Clinical Oncology. 2011-12-01
Journal Articles
- E6201, an Intravenous MEK1 Inhibitor, Achieves an Exceptional Response in BRAF V600E-Mutated Metastatic Malignant Melanoma with Brain MetastasesMitesh J Borad, Raoul Tibes, Michael S Gordon, Ronald L Korn, Investigational New Drugs
Press Mentions
- Breakthrough Radiomic Technology Patent Issued to Imaging EndpointsJanuary 13th, 2020
- Expert Radiologist Ronald L. Korn, MD, to Be Recognized as a 2016 Top Doctor in Scottsdale, ArizonaDecember 12th, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: